Faye N. Hant

Abatacept in Early Diffuse Cutaneous Systemic Sclerosis: Results of a Phase <scp>II</scp> Investigator‐Initiated, Multicenter, Double‐Blind, Randomized, Placebo‐Controlled Trial

Dinesh Khanna, Cathie Spino, Sindhu R. Johnson et al. · Arthritis & Rheumatology · 2019 · 218 citations · Full text

Endothelial Fli1 Deficiency Impairs Vascular Homeostasis

Yoshihide Asano, Lukasz Stawski, Faye N. Hant et al. · American Journal Of Pathology · 2010 · 194 citations · Full text

Inflammation, Vascular Disease, Cardiovascular Disease +7

Surfactant Protein D and KL-6 as Serum Biomarkers of Interstitial Lung Disease in Patients with Scleroderma

Faye N. Hant, A Ludwicka, Hejing Wang et al. · The Journal of Rheumatology · 2009 · 171 citations · Full text

Global skin gene expression analysis of early diffuse cutaneous systemic sclerosis shows a prominent innate and adaptive inflammatory profile

Brian Skaug, Dinesh Khanna, William R. Swindell et al. · Annals of the Rheumatic Diseases · 2019 · 167 citations · Full text

Reliability and Minimal Clinically Important Differences of FVC. Results from the Scleroderma Lung Studies (SLS-I and SLS-II)

Suzanne Kafaja, Philip J. Clements, Holly Wilhalme et al. · American Journal of Respiratory and Critical Care Medicine · 2017 · 120 citations · Full text